Industry Perspectives

Expanded high-value end-to-end solution positions business for rapid growth in multi-billion dollar functional GI market

Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy outcome and expansion to larger global patient studies

Efforts to move beyond long-term steroid use are accelerating, with growing awareness of steroid toxicity, new tools to guide tapering, and emerging therapies offering safer alternatives.

Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets

A breakthrough from AI|ffinity and NexMR was achieved with a 100-fold affinity improvement in the initial round of drug discovery using ultrafast NMR screening and AI-driven lead generation against intrinsically disordered protein targets.

Optimizing CRISPR delivery is essential to unlocking its full potential in drug discovery, enabling efficient, precise, and reproducible gene editing across diverse cell types and experimental contexts.

Peer-reviewed study in the International Wound Journal indicates that Aurase Wound Gel can achieve debridement without any additional pain to the patient

Bio-Rad Laboratories, Inc has launched four new Droplet Digital PCR platforms.

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market

Artificial intelligence is prompting a fundamental rethink of clinical trial design and execution, with the potential to reduce patient burden, improve data quality, and accelerate development timelines. 

As demand grows for high-resolution, multiplexed tissue analysis, automation is key to enabling broader access and clinical application.